Victor Ona

Merck (Germany) — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index5.0kcitations35works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mitochondrial Function and Pathology(6), Genetic Neurodegenerative Diseases(6), Electrolyte and hormonal disorders(4), Neuroscience and Neuropharmacology Research(3), Cell death mechanisms and regulation(3)

Publications35 total

Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial
Journal of Psychopharmacology·2024· 2 citedOpen Access
Zuranolone Safety and Tolerability in Adults with Postpartum Depression: Analyses from SKYLARK, a 50 mg Placebo-Controlled Study
CNS Spectrums·2024Open Access
Effects of zuranolone on next-day simulated driving in healthy adults
Psychopharmacology·2024· 3 citedOpen Access
Long-term safety and frequency of repeat zuranolone treatment in patients with major depressive disorder rolling over from the randomised CORAL Study into the open-label SHORELINE Study
European Psychiatry·2024Open Access
Safety, Tolerability, and Pharmacodynamics of the <scp>ADAMTS</scp>‐5 Nanobody <scp>M6495</scp>: Two Phase 1, <scp>Single‐Center</scp>, <scp>Double‐Blind</scp>, Randomized, <scp>Placebo‐Controlled</scp> Studies in Healthy Subjects and Patients With Osteoarthritis
ACR Open Rheumatology·2024· 13 citedOpen Access
Zuranolone fafety and tolerability in adults with postpartum depression: analyses from SKYLARK, a 50 mg placebo-controlled study
Neuroscience Applied·2024Open Access
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
Pharmacology Research & Perspectives·2021· 44 citedOpen Access
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study
Annals of the Rheumatic Diseases·2021· 124 citedOpen Access
Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus
Lara D. Veeken·2021· 24 citedOpen Access
Long-term efficacy and safety of intra-articular sprifermin in patients with knee osteoarthritis: results from the 5-year forward study
Osteoarthritis and Cartilage·2020· 4 citedOpen Access
FRI0194 INTEGRATED SAFETY PROFILE OF ATACICEPT FROM ALL CLINICAL STUDIES TO DATE
Annals of the Rheumatic Diseases·2019Open Access
215 First-in-man study evaluating the safety, tolerability, pharmacokinetics and concentrationQT analysis of the novel BTK inhibitor evobrutinib (M2951) in healthy volunteers
Abstracts·2019Open Access
212 Phase 2, randomized, double-blind, placebo-controlled, dose-finding study, evaluating the Bruton’s tyrosine kinase inhibitor evobrutinib in patients with systemic lupus erythematosus: study design
Abstracts·2019· 2 citedOpen Access
210 Integrated safety profile of atacicept from all clinical studies to date
Abstracts·2019· 1 citedOpen Access
FRI0322 Rationale for the atacicept dose for a phase iii study in patients with highly active and auto-antibody positive sle
Annals of the Rheumatic Diseases·2018Open Access
Role of preserving the bladder neck in urinary continence in patients with radical retropubic prostatectomy
2014
V13 Robot assisted repair of a complex vesicovaginal fistula using an omental flap, according to Kiricuta &amp; Goldstein technique
European Urology Supplements·2012
UP-1.71: Urinary continence after open, laparoscopic and robotic prostatectomy: a single center experience
Urology·2010
CARDIOVASCULAR RISK IN THE FIRST YEAR OF HRT
Maturitas·2009
53 POSTER Combination treatment of VEGFR inhibitor AV-951 and rapamycin reveals distinct mechanisms of each agent's anti-tumor activity
European Journal of Cancer Supplements·2008
page 1 of 2Next →

Frequent Co-authors

Robert M. Friedlander(15), Mingwei Li(8), Philip E. Stieg(7), Robert J. Ferrante(5), Serge Przedborski(4), L. John Andrews(4), Amy Kao(4), Martin Drozda(3), Mingwei Li(3), J. Jang‐Ho(3), Sohail Q. Khan(3), Junying Yuan(3), Hans Guehring(3), Flavie Moreau(3), Asger Reinstrup Bihlet(3), C. Ladel(3), Indrani Nandy(3), Margaret K Moseley(3), Seth Levin(3), Peter Chang(3)